[ Diretor: Mário Frota [ Coordenador Editorial: José Carlos Fernandes Pereira [ Fundado em 30-11-1999 [ Edição III [ Ano XII

terça-feira, 10 de outubro de 2017

Pharma innovation

shutterstock_350093090 [Shutterstock]

In June 2016 particularly, EU health ministers called on the European Commission to perform an overview of the current EU legislative tools and incentives that aim to facilitate investment in the development of medicinal products.

On the other hand, many suggest that such an approach would have detrimental consequences for innovation in the pharma sector. Experts claim that policymakers should instead focus on other healthcare fields to save costs, considering that pharmaceutical expenditure has remained stable over recent years.

Sem comentários: